ArticleNeurosurgical review2026
Association between trajectory of intracranial pressure and all-cause mortality in patients with non-traumatic subarachnoid hemorrhage: A retrospective cohort study from 2008 to 2022.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Our study aimed to assess the association between intracranial pressure (ICP) trajectories and 30-day, 90-day, 180-day, and 365-day all-cause mortality in patients with non-traumatic subarachnoid hemorrhage (SAH). We identified patients diagnosed with non-traumatic SAH from the MIMIC-IV 3.1 database. Group-based trajectory modeling was applied to identify ICP trajectories with selection based on Log-likelihood, Akaike information criterion (AIC), Bayesian information criterion (BIC), Hannan-Quinn information criterion (HQIC), Odds of correct classification (Occ), and Average posterior probability (Avepp) to determine the optimal number of classes. Logistic regression with a multi-model approach was used to compare all-cause mortality among patients with different ICP trajectories. Subgroup analyses were performed to assess the interactions. To demonstrate robustness, the relationship between traditional ICP metrics and all-cause mortality was evaluated using restricted cubic splines (RCS) and receiver operating characteristic (ROC) curves. Of the 1052 patients with non-traumatic SAH, 312 were included. Four distinct ICP trajectories were identified: (1) Class 1 (sustained decline and stabilization at a low level), (2) Class 2 (stabilization at the lowest level), (3) Class 3 (initial decline followed by elevation with fluctuations at moderate-to-high levels), and (4) Class 4 (initial highest level followed by decline with high fluctuations). Class 4 had significantly higher mortality rates at all time points. Additionally, multi-model logistic regression analyses showed that, compared to Class 1, Class 4 was associated with a higher risk of death at 30 days (adjusted OR: 5.36, 95%CI: 1.13-25.50, P = 0.035), 90 days (adjusted OR: 5.54, 95%CI: 1.21-25.28, P = 0.027), 180 days (adjusted OR: 7.66, 95%CI: 1.75-33.55, P = 0.007), and 365 days (adjusted OR: 6.74, 95%CI: 1.52-29.89, P = 0.012). RCS analysis revealed a non-linear association between average ICP and ICU mortality, with no linear association observed for other mortality outcomes. Threshold effect analysis identified the optimal threshold of the average ICP as 11.08mmHg. The AUCs of %ICP>20mmHg, average ICP, and baseline ICP for predicting 30-day mortality were 0.567, 0.567, and 0.542, respectively. Furthermore, subgroup analyses showed no interactions between ICP trajectory classes and subgroups of age, sex, race, hypertension, external ventricular drainage, or mannitol use. In patients with non-traumatic SAH, early ICP trajectories were significantly associated with 30-day, 90-day, 180-day, and 365-day all-cause mortalities. This indicates that ICP trajectories can serve as effective indicators for prognostic assessments.
Indexed as
Identifiers
42189255What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.